Related Experiment Video

Updated: Sep 26, 2025

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.6K

Selvester Score May Be a Predictor of ICD Therapies in Patients with Non-Ischemic Dilated Cardiomyopathy

Mevlut Serdar Kuyumcu1, Mehmet Hakan Uzun2, Yasin Ozen3

  • 1Department of Cardiology, Isparta Suleyman Demirel University, Faculty of Medicine, Isparta,Turkey.

Brazilian Journal of Cardiovascular Surgery
|April 18, 2022
PubMed

Insights

A high Selvester score, a measure of ventricular scar tissue, predicts implantable cardioverter-defibrillator (ICD) therapies in dilated cardiomyopathy (DCM) patients. This non-invasive method aids in treatment decisions for DCM.

Area of Science:

  • Cardiology
  • Medical Imaging

Background:

  • The efficacy of implantable cardioverter-defibrillators (ICDs) in non-ischemic dilated cardiomyopathy (DCM) remains debated.
  • Cardiac magnetic resonance (CMR) studies suggest a link between ventricular scar tissue and ICD shocks.

Purpose of the Study:

  • To investigate the relationship between the Selvester score, a measure of ventricular scar, and ICD therapies in DCM patients.
  • To determine if the Selvester score can predict ICD therapies in this population.

Main Methods:

  • Retrospective analysis of 48 DCM patients who received ICDs.
  • Comparison of Selvester scores between patients who received ICD therapy (n=10) and those who did not (n=38).

Main Results:

  • Patients receiving ICD therapy had significantly higher Selvester scores (P<0.001).
  • A strong positive correlation (r=0.843, P=0.002) was found between Selvester score and ICD shock therapy.
  • Selvester score independently predicted ICD therapy (P=0.004) and showed high diagnostic accuracy (AUC, P<0.001).

Conclusions:

  • A high Selvester score is a significant predictor of ICD therapies in DCM patients.
  • The Selvester score, an inexpensive and non-invasive metric, can assist in clinical decision-making for ICD implantation in DCM.
Abstract

Keywords:
CardiomyopathyDefibrillatorsDilatedElectrocardiographyImplantableRisk FactorsSensitivity and SpecificitySurvival RateTreatment Outcome

More Related Videos

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

24.4K
Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice12:12

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice

Published on: February 14, 2017

16.2K

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
43
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
50
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
55
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
34
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
53
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
73